Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Panic Disorders Market Today And What Is Its Future Size?
The market size for panic disorders has been showing consistent growth in the past few years. The market which stands at $10.73 billion in 2024, is expected to reach $11.15 billion by 2025, increasing at a compound annual growth rate (CAGR) of 3.9%. The historic era growth is credited to factors such as the usage of antidepressant therapies, rising awareness about mental health, elevated levels of stress, wider access to mental health services, and improvements in diagnostic standards.
The market size for panic disorders is predicted to witness a robust expansion in the coming years. It is poised to reach a value of $13.97 billion by 2029, growing at a CAGR of 5.8%. The advancement in the forecasted period is due to factors like the advent of new pharmacological cures, telepsychiatry operations, emphasis on associated conditions, global initiatives for mental health, utilization of pharmacogenomics in treatment protocols, and public awareness campaigns. Key trends for the forecasted period encompass digital interventions for mental health, telemedicine for the treatment of panic disorders, innovations in the pharmaceutical sector, studies in neurobiology, and the rise in remote surveillance and wearable tech.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp
Which Demand Drivers Are Strengthening The Panic Disorders Market?
The surge in psychiatric patients is predicted to fuel the panic disorder market’s expansion in the future. Psychiatric patients, who are individuals suffering from mental disorders or illnesses that may interfere with their cognition, emotions, and social conduct, are prone to panic disorder or severe panic attacks. Common treatments for psychiatric patients diagnosed with panic disorder include a mix of therapeutic methods, medication, and lifestyle modifications to help reduce panic attack symptoms, enhance the patient’s overall life quality, and assist them in handling their condition more effectively. For instance, the State of Mental Health in America 2022 report, released by Mental Health America, a US-based mental health advocate organization, in October 2022 indicated that the count of psychiatric patients or adults with any mental illnesses surged to 49,564,000, accounting for 19.86% of the total US population in 2022, an increase from 47,132,000, or 19.00% of the total US population in 2021. Hence, the escalating number of psychiatric patients is anticipated to stimulate the growth of the panic disorder market.
Which Segment Accounts For The Largest Share In The Panic Disorders Market?
The panic disordersmarket covered in this report is segmented –
1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder
2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
Subsegments:
1) By Agoraphobia: Situational Agoraphobia; Non-Situational Agoraphobia
2) By Social Anxiety Disorder (SAD): Performance Anxiety; Generalized Social Anxiety
3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD; Harm OCD; Checking OCD; Symmetry OCD
4) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder
5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD; Chronic PTSD; Complex PTSD
6) By Major Depressive Disorder: Recurrent Major Depressive Disorder; Single Episode Major Depressive Disorder
Which Disruptive Trends Are Driving Change Across The Panic Disorders Market?
Leading organizations in the panic disorder industry are concentrating their efforts on the development of sophisticated medications, like extended-release capsules, as a strategy of maintaining their market dominance. These types of capsules, which gradually release the active ingredients over a period of time—usually 12 to 24 hours—are designed to treat conditions that demand long-term medication. As an illustration, Granules India Ltd., a pharmaceutical entity based in India, obtained the abbreviated new drug application (ANDA) endorsement from the US Food & Drug Administration (USFDA) for their Venlafaxine hydrochloride extended-release capsules in May 2023. This proves the drug’s bioequivalence with Effexor XR Extended-Release Capsules, the reference-listed drug product (RLD) made by Upjohn US 2 LLC. Generally, Venlafaxine HCl extended-release capsules, which function by enhancing the levels of serotonin and norepinephrine in the brain, are recommended for management of a variety of conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). Typically, the starting dosage is 75 mg per day, but this can be increased based on the doctor’s discretion.
Which Companies Hold A Competitive Edge In The 703 Market?
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report
Which Region Is Forecasted To Lead The Panic Disorders Market In The Coming Years?
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp
Browse Through More Reports Similar to the Global Panic Disorders Market 2025, By The Business Research Company
Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2025
Merkel Cell Carcinoma Treatment Global Market Report 2025
Basal Cell Carcinoma Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
